Recent Updates
Recently added Catalysts
KYMR Positive Sentiment Score: 60/100

Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2

Thursday, April 25, 2024 1 min read
Key Takeaway: Kymera Therapeutics, a clinical-stage biopharmaceutical company, has announced that it will report its first quarter 2024 financial results on May 2, 2024. The company specializes in targeted protein degradation and will host a conference call at 8:30 a.m. ET for stakeholders. Interested parties can access the call via phone or through a live webcast on the company's website. A replay of the webcast will also be available after the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kymera Therapeutics will report its financial results soon, indicating transparency.
  • The company is advancing a new class of medicines, suggesting innovation.
  • The scheduled conference call allows for direct communication with investors.

Full Press Release Details

WATERTOWN, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), will report first quarter 2024 financial results on May 2, 2024, and will host a conference call at 8:30 a.m. ET.
To access the May 2 conference call via phone, please dial +1 (833) 630-2127 (US) or +1 (412) 317-1846 (International) and ask to join the Kymera Therapeutics call. A live webcast of the Company’s conference call will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcast will be archived and available following the event.
About Kymera Therapeutics
Investor and Media Contact:
Vice President, Investor Relations
investors@kymeratx.com

Tags

Targeted Protein Degradation

Frequently Asked Questions

When will Kymera Therapeutics report Q1 2024 financial results?

Kymera Therapeutics will report its Q1 2024 financial results on May 2, 2024.

What time is the Kymera conference call on May 2?

The conference call is scheduled for 8:30 a.m. ET on May 2, 2024.

How can I access the Kymera conference call?

You can join the call by dialing +1 (833) 630-2127 in the US or +1 (412) 317-1846 internationally.

Where can I find the webcast of the conference call?

The live webcast can be accessed in the Investors section of Kymera's website.

Will there be a replay of the conference call available?

Yes, a replay of the conference call will be archived and available post-event.

Tags: KYMR Viatris Investor Conferences Healthcare Kymera Therapeutics NASDAQ financial results targeted protein degradation biopharmaceutical
Last updated: Apr 25, 2024